Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
for
Acute Treatment of Migraine
Location: Statesville NC, Winston-Salem NC, Washington D.C. DC,
Sponsor: Pfizer
Sex: All
Age: 6 - 11
Code: NCT06995729
Phase 1, Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Deerfield IL, Concord NC, Charlotte NC, Monroe NC,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase 2, Recruiting
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Winston-Salem NC, Chapel Hill NC, Durham NC,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase 1, Phase 2, Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Winston-Salem NC, Knoxville TN, Columbia MD, Canton OH,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Winston-Salem NC, Charlotte NC, Pittsburgh PA,
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase 3, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Winston-Salem NC, Durham NC, Norfolk VA, Fairfax VA,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase 2, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Winston-Salem NC, Charlotte NC, Norfolk VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase 3, Recruiting
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
for
Acute Myeloid Leukemia, in Relapse,
Location: Winston-Salem NC, Charlotte NC, Houston TX
Sponsor: ARCE Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06680752
Phase 1, Phase 2, Recruiting
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: Winston-Salem NC, Charlotte NC, Spartanburg SC,
Sponsor: Stichting European Myeloma Network
Sex: All
Age: 18+
Code: NCT05028348
Phase 3, Recruiting
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
for
AML, Adult
Location: Winston-Salem NC, Charlotte NC, Houston TX,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT04964518
Phase 1, Phase 2, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
for
Septic Shock, Sepsis, Hypovolemia
Location: Winston-Salem NC, Savannah GA, Kansas City MO,
Sponsor: Vivacelle Bio
Sex: All
Age: 18+
Code: NCT06072430
Phase 3, Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Winston-Salem NC, Charlotte NC, Baltimore MD,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Sex: All
Age: 18+
Code: NCT07223814
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Winston-Salem NC, Chapel Hill NC, Charlotte NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Location: Winston-Salem NC, Richmond VA, Gainesville GA,
Sponsor: HistoSonics, Inc.
Sex: All
Age: 22+
Code: NCT06486454
Recruiting
Effects of Graded Protein Intake on Body Composition in Older Adults
for
Sarcopenia
Location: Winston-Salem NC
Sponsor: Wake Forest University
Sex: All
Age: 55 - 70+
Code: NCT04845282
Recruiting
MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab
for
Chronic Lymphocytic Leukemia (CLL),
Location: Winston-Salem NC, Durham NC, Charlotte NC, Boston MA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07024706
Phase 2, Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Winston-Salem NC, Salisbury NC, Roanoke VA,